Efficacy and Safety Study of Prolonged-Release Fampridine in Participants With Multiple Sclerosis
Clinical trial NCT02219932 · COMPLETED
Trial details
- NCT number
- NCT02219932
- Sponsor
- Biogen
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-09-01
- Primary completion
- 2016-02-01
- Enrollment
- 646
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.